Rentschler Biotechnologie Expands Single-Use Capabilities

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-05-06-2015
Volume 11
Issue 5

Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies.

 

GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH have announced the handover of GE Healthcare’s 1000th ÄKTAprocess and the expansion of Rentschler’s biopharmaceutical manufacturing capabilities in Laupheim, Germany.

ÄKTAprocess, GE’s automated process and manufacturing scale chromatography system, has gone into operation as part of Rentschler’s recently expanded single-use manufacturing suite. Other GE biomanufacturing technologies, such as the XDR 2000-L bioreactor, and seed trains of 50 L, 200 L and 500 L are featured in Rentschler’s single-use manufacturing line.



Source: Rentschler Biotechnologie GmbH

Articles in this issue
Better Control of the API Supply Chain?
Better Control of the API Supply Chain?
Figure-2-New-1428326648955-New-1430776522618.jpg
Big Pharma Feeds Big CMO Growth
Capsugel Produces DPI Phase 2 Trial Supplies
Chinese API Manufacturer Warned for Data Integrity Issues
Mylan Recalls Injectables Due to Visible Particulate Matter
FDA Releases Final Biosimilar Guidance
Vetter Serializes First Product for South Korea
IDT Biologika Vaccine Facility Recognized
SGS Completes Expansion at Mumbai Facility
Serialization: Deja Vu All Over Again?
Colin.jpg
Gauging Change in Europe’s Sterile Manufacturing Market
Rentschler Biotechnologie Expands Single-Use Capabilities
Recipharm Invests in Sythonics
Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New Almac Pharma Services Commercial Manufacturing Facility Opens in Northern Ireland

Patrick Lavery
March 11th 2025
Article

The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Noramco Group Establishes Sterile Injectable Manufacturing Capabilities with $25 Million Investment

Patrick Lavery
March 10th 2025
Article

The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Woman face silhouette in profile with group of multicultural and multiethnic women faces inside.Concept of racial equality anti-racism and a woman who gives voice to other women. Allyship | Image Credit: © melita – stock.adobe.com

International Women’s Day 2025: Improving Innovation in Industry

Felicity Thomas
March 8th 2025
Article

Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions.

factory of the pharmaceutical industry. pills on the conveyor | Image Credit: © Mike Mareen - © Mike Mareen - stock.adobe.com

How Continuous Manufacturing is Advancing Bio/Pharma Production

Feliza Mirasol
March 8th 2025
Article

Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges.